Download
1 / 3
0 likes | 13 Views
The Genomics Market is projected to reach $70.52 billion by 2031, at a CAGR of 11.1% from 2024 to 2031. Genomics studies the structure, function, evolution, and mapping of genomes. It includes several operations, ranging from sequencing to analysis, to understand the genetic basis of various biological phenomena.
E N D
GENOMICS INNOVATORS: EXPLORING THE TOP 10 COMPANIES RESHAPING THE FUTURE
The global Genomics Market is poised for significant expansion, with forecasts indicating a value surpassing $70.52 billion by 2031, showcasing a resilient Compound Annual Growth Rate (CAGR) of 11.1% from 2024 to 2031. Genomics, the study of genomes encompassing structure, function, evolution, and mapping, plays a pivotal role across various sectors, including medicine, agriculture, biotechnology, and ecology. By unraveling the genetic blueprint of organisms, genomics enables targeted therapies, agricultural innovations, and insights into evolutionary dynamics and ecological relationships. Market Dynamics Driving Growth: The growth of the genomics market is propelled by several factors, including the rising prevalence of genetic diseases, integration of genomic data in clinical practices, increased funding for genomics projects, expanding applications in healthcare, and heightened pharmaceutical research and development investments. However, challenges such as the absence of standardized approaches and concerns regarding data security and privacy hinder market expansion. Furthermore, the adoption of personalized medicines and gene therapies presents new growth avenues, albeit accompanied by challenges such as the scarcity of skilled bioinformatics professionals and the commercialization and scalability of genomic technologies. Top 10 Companies Shaping the Genomics Landscape:https://meticulousblog.org/top-10- companies-in-genomics-market/ Here are the leading companies driving innovation and progress in the Genomics Market: 1. Thermo Fisher Scientific Inc. (U.S.): With a rich history dating back to 2006, Thermo Fisher Scientific leads the pack in biotechnology. Headquartered in Massachusetts, U.S., their comprehensive suite of genomics products spans the globe, supporting life sciences research and patient diagnostics. 2. Illumina, Inc. (U.S.): Since its inception in 1998, Illumina has been synonymous with groundbreaking sequencing and array-based solutions. Based in California, U.S., their products are pivotal in genetic and genomic analysis across various sectors, from research institutions to commercial laboratories. 3. Qiagen N.V. (Netherlands): Venlo, Netherlands, is home to Qiagen, a trailblazer in sample and assay technologies. Their offerings in molecular diagnostics and applied testing are indispensable in both academic and pharmaceutical research worldwide. 4. Danaher Corporation (U.S.): Founded in 1969, Danaher Corporation has evolved into a global science and technology juggernaut. Operating in over 60 countries, their genomics products underpin advancements in life sciences, diagnostics, and environmental sectors. 5. Agilent Technologies, Inc. (U.S.): California-based Agilent Technologies specializes in application-focused solutions for life sciences and diagnostics. Their genomic products, ranging from mutation detection to gene expression profiling, are instrumental in unraveling genetic mysteries. Page 1 of 2 © Meticulous Research| sales@meticulousresearch.com
Download Free Sample Report:https://www.meticulousresearch.com/download-sample- report/cp_id=1262 6. Bio-Rad Laboratories, Inc. (U.S.): Since 1952, Bio-Rad Laboratories has been a stalwart in developing products for life science research and clinical diagnostics. With facilities across the western U.S. and Europe, their genomics offerings are driving innovation in biological analysis. 7. Pacific Biosciences of California, Inc. (U.S.): California's Pacific Biosciences is synonymous with advancing sequencing solutions. Their technology aids researchers worldwide in solving genetically complex problems across diverse sectors. 8. Oxford Nanopore Technologies Plc. (U.K.): Founded in 2005, Oxford Nanopore Technologies pioneers real-time DNA/RNA sequencing. Operating in over 120 countries, their nanopore-based platform is revolutionizing genomic analysis. 9. Reevity, Inc. (Formerly PerkinElmer, Inc.) (U.S.)- Formerly known as PerkinElmer, Revvity Inc. is a multinational powerhouse offering solutions across the life sciences and diagnostics spectrum. Their genomics products, distributed in over 190 countries, are driving advancements in research and diagnostics. 10. BGI Genomics Co.,Ltd. (China): Shenzhen-based BGI Genomics is a global provider of precision medicine solutions. With an extensive network spanning over 100 countries, their integrated genomic sequencing and proteomic services are at the forefront of medical research. About Us: We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition. Through our mixed bag of research offerings – syndicated research, custom research, and analyst engagement — we enable smart decision making to enhance business performance for global organizations. Our focus is also on finding answers to the challenging questions that global business leaders face on a daily basis. Each year, we deliver more than 300 syndicate studies and 60+ consulting projects across eight industry verticals in 20+ geographic markets. Contact Us: Meticulous Research® Email-sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 2 of 2 © Meticulous Research| sales@meticulousresearch.com
